Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HDMA joins FDA counterfeit alert network

Executive Summary

The Healthcare Distribution Management Association has joined FDA's counterfeit alert network. As a member of the network, the wholesaler group will distribute time-sensitive FDA messages and information on specific counterfeit incidents to member companies. It will also provide educational messages about counterfeit drugs, as well as information needed to recognize and report suspect or counterfeit drug products. FDA announced the creation of the counterfeit alert network when it released its "Combating Counterfeit Drugs" report in 2004 (1"The Pink Sheet" Feb. 23, 2004, p. 17). Other members of the network include the Academy of Managed Care Pharmacy, the National Association of Chain Drug Stores and the National Community Pharmacists Association...

You may also be interested in...

FDA Anticounterfeiting PSA Urges Public To Verify Web Pharmacy Licensure

An FDA counterfeit drugs 1public service announcement directs consumers to look for the "Verified Internet Pharmacy Practice Sites" seal when purchasing drugs on the internet

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts